Competition Commission of India (CCI) has approved Strides Shasun’ plan to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore.
Tags : COMPETITION COMMISSION OF INDIA (CCI) STRIDES SHASUN SUN PHARMACEUTICAL
Share :